Inflammation-suppressing cornea-in-a-syringe with anti-viral GF19 peptide promotes regeneration in HSV-1 infected rabbit corneas

Autor: Egidijus Simoliunas, Inés Ruedas-Torres, Yolanda Jiménez-Gómez, Elle Edin, Mozhgan Aghajanzadeh-Kiyaseh, Mostafa Zamani-Roudbaraki, Rimvydas Asoklis, Milda Alksne, Neethi C. Thathapudi, Bijay K. Poudel, Ieva Rinkunaite, Kasparas Asoklis, Monika Iesmantaite, Laura Ortega-Llamas, Almantas Makselis, Marcelo Munoz, Daiva Baltriukiene, Virginija Bukelskiene, Jaime Gómez-Laguna, Miguel González-Andrades, May Griffith

Publikováno v: npj Regenerative Medicine, Vol 9, Iss 1, Pp 1-15 (2024)

Abstract Pathophysiologic inflammation, e.g., from HSV-1 viral infection, can cause tissue destruction resulting in ulceration, perforation, and ultimately blindness. We developed an injectable Cornea-in-a-Syringe (CIS) sealant-filler to treat damage

Externí odkaz: https://doaj.org/article/1b496cbaf026441686aba5c8afa0eacd

Acquired Nasolacrimal Duct Obstruction: Clinical and Histological Findings of 275 Cases

Autor: Rimvydas Asoklis, A Cimbalas, Ruta Jaruseviciene, Donatas Petroška, Andrius Ruzgys, Almantas Makselis, Justinas Besusparis, Aiste Kadziauskiene

Publikováno v: BMC Ophthalmology, Vol 22, Iss 1, Pp 1-8 (2022)
BMC ophthalmology, London : BioMed Central Ltd, 2022, vol. 22, iss. 1, art. no. 12, p. [1-8]
BMC Ophthalmology

Background Acquired nasolacrimal duct obstruction is a blockage of the lacrimal outflow system usually caused by local nonspecific inflammation of the lacrimal sac and the nasolacrimal duct. However, cases exist where the primary nasolacrimal system

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e94a3ee34c26930f5d6db4a1622d030e
https://doi.org/10.21203/rs.3.rs-608601/v1